BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 16437573)

  • 1. Neurological impact of vasopressin dysregulation and hyponatremia.
    Bhardwaj A
    Ann Neurol; 2006 Feb; 59(2):229-36. PubMed ID: 16437573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin antagonists: role in the management of hyponatremia.
    Yeates KE; Morton AR
    Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH; Serrano C
    Int J Cardiol; 2007 Aug; 120(1):1-9. PubMed ID: 17346825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A; Whaley-Connell A; McFarlane S; Sowers JR
    Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin excess and hyponatremia.
    Pham PC; Pham PM; Pham PT
    Am J Kidney Dis; 2006 May; 47(5):727-37. PubMed ID: 16632011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyponatremia and hypernatremia: disorders of water balance.
    Agrawal V; Agarwal M; Joshi SR; Ghosh AK
    J Assoc Physicians India; 2008 Dec; 56():956-64. PubMed ID: 19322975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management.
    Miller M
    J Am Geriatr Soc; 2006 Feb; 54(2):345-53. PubMed ID: 16460390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS
    J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyponatremia in neurologic patients: consequences and approaches to treatment.
    Diringer MN; Zazulia AR
    Neurologist; 2006 May; 12(3):117-26. PubMed ID: 16688013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin antagonism: potential impact on neurologic disease.
    Rabinstein AA
    Clin Neuropharmacol; 2006; 29(2):87-93. PubMed ID: 16614541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia in the neurosurgical patient: epidemiology, pathophysiology, diagnosis, and management.
    Fraser JF; Stieg PE
    Neurosurgery; 2006 Aug; 59(2):222-9; discussion 222-9. PubMed ID: 16883162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms, risks, and new treatment options for hyponatremia.
    Ghali JK
    Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The science behind hyponatremia and its clinical manifestations.
    Schrier RW
    Pharmacotherapy; 2011 May; 31(5 Suppl):9S-17S. PubMed ID: 21923421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arginine vasopressin receptor antagonists in hyponatremia in the elderly.
    Miller M
    Geriatrics; 2007 Jul; 62(7):20-6. PubMed ID: 17620018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatremia in psychiatric patients: update on evaluation and management.
    Siegel AJ
    Harv Rev Psychiatry; 2008; 16(1):13-24. PubMed ID: 18306096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.
    Robertson GL
    Am J Med; 2006 Jul; 119(7 Suppl 1):S36-42. PubMed ID: 16843083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C; Pistrosch F; Herbrig K; Gross P
    Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin receptor antagonists: potential indications and clinical results.
    Arai Y; Fujimori A; Sudoh K; Sasamata M
    Curr Opin Pharmacol; 2007 Apr; 7(2):124-9. PubMed ID: 17292670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F; Blei AT; Blendis LM; Thuluvath PJ
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.